Halozyme licenses drug delivery technology to Vertex for $15 million
Go back to Halozyme licenses drug delivery technology to Vertex for $15 million| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 110.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.76 | 52 Week High | $18.39 | |||
| Open | $110.76 | 52 Week Low | $6.96 | |||
| Day High | $110.76 | P/E | N/A | |||
| Day Low | $110.76 | EPS | $-0.58 | |||
| Volume | 398 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 557.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $557.96 | 52 Week High | $134.71 | |||
| Open | $557.96 | 52 Week Low | $73.31 | |||
| Day High | $557.96 | P/E | N/A | |||
| Day Low | $557.96 | EPS | $-1.98 | |||
| Volume | 175 | |||||
